Korea Investment CORP bought a new stake in Centene Corporation (NYSE:CNC – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,003,186 shares of the company’s stock, valued at approximately $64,395,000. Korea Investment CORP owned about 0.20% of Centene at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. DV Equities LLC bought a new stake in shares of Centene in the 4th quarter valued at $26,000. IFC & Insurance Marketing Inc. bought a new position in Centene during the fourth quarter worth $28,000. SBI Securities Co. Ltd. lifted its holdings in Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after buying an additional 406 shares during the period. MidFirst Bank bought a new stake in Centene during the second quarter valued at $32,000. Finally, Bayban bought a new stake in Centene during the fourth quarter valued at $33,000. Institutional investors own 93.63% of the company’s stock.
Insiders Place Their Bets
In other Centene news, General Counsel Christopher Koster sold 47,603 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $65.36, for a total value of $3,111,332.08. Following the transaction, the general counsel directly owned 305,354 shares of the company’s stock, valued at approximately $19,957,937.44. This trade represents a 13.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on Centene
Centene Trading Up 1.2%
Shares of Centene stock opened at $64.94 on Friday. The stock has a market capitalization of $32.08 billion, a PE ratio of -6.22, a price-to-earnings-growth ratio of 0.34 and a beta of 1.08. Centene Corporation has a 52 week low of $28.24 and a 52 week high of $69.36. The stock has a 50 day moving average price of $64.96 and a two-hundred day moving average price of $52.40. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15.
Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Monday, July 27th. The company reported $2.51 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The company had revenue of $53.58 billion for the quarter, compared to analyst estimates of $47.64 billion. During the same period in the prior year, the firm earned ($0.16) earnings per share. Centene’s revenue for the quarter was up 9.9% on a year-over-year basis. As a group, equities analysts anticipate that Centene Corporation will post 4.89 earnings per share for the current fiscal year.
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Further Reading
- Five stocks we like better than Centene
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
